pl6 Alterations and Deletion Mapping of 9p21-p22 in Malignant Mesothelioma

Cancer Research

Volumn 54, Issue 21, 1994, Pages 5547-5551

  Buckler, Alan J ^e   Klein, Walter M ^a   Bell, Daphne W ^a   Lee, Wen Ching ^a   Altomare, Deborah A ^a   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR PROTEIN; PROTEIN P16;

ARTICLE; CHROMOSOME 9P; CLINICAL ARTICLE; GENE DELETION; GENE MAPPING; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT MESOTHELIOMA; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARRIER PROTEINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PROBES; DOWN-REGULATION; GENE DELETION; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; HUMANS; MESOTHELIOMA; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0027960580     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Knudson, A.G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA, 90: 10914-10921, 1993.
2. Cannon-Albright, L.A. Goldgar, D.E. Meyer, L.J. Lewis, C.M. Anderson, D.E. Fountain, J.W. Hegi, M.E. Wisman, R.W. Petty, E.M. Bale, A.E. Olopade, O.I. Diaz, M.O. Kwiatkowski, D.J. Piepkorn, M.W. Zone, J.J. and Skolnick, M.H. Assignment of a locus for familial melanoma, MLM, to chromosome 9p. 3-p. 2. Science (Washington DC), 258: 1148-1152, 1992.
3. Diaz, M.O. Rubin, C.M. Harden, A. Ziemen, S. Larson, R. Le Beau, M.M. and Rowley, J.D. Deletions of interferon genes in acute lymphoblastic leukemia. N. Engl. J. Med. 322: 77-82, 1990.
4. James, C.D. He, J. Carlbom, E. Nordenskjold, M. Cavenee, W. and Collins, V.P. Chromosome 9 deletion mapping reveals interferon α and interferon β-1 gene deletions in human glial tumors. Cancer Res. 51: 1684-1688, 1991.
5. Cheng, J.Q. Jhanwar, S.C. Lu, Y.Y. and Testa, J.R. Homozygous deletions within chromosome region 9p. 1-p. 2 in human malignant mesotheliomas. Cancer Res. 53: 4761-4764, 1993.
6. Fountain, J.W. Karayiorgou, M. Ernstoff, M.S. Kirkwood, J.M. Vlock, D.R. Titus-Ernstoff, L. Bouchard, B. Vijayasaradhi, S. Houghton, A.N. Lahti, J. Kidd, V.J. Housman, D.E. and Dracopoli, N.C. Homozygous deletions within human chromosome band 9p. 1 in melanoma. Proc. Natl. Acad. Sci. USA, 89: 10557-10561, 1992.
7. Olopade, O.I. Buchhagen, D.L. Malik, K. Sherman, J. Nobori, T. Bader, S. Nau, M.M. Gazdar, A.F. Minna, J.D. and Diaz, M.O. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res. 53: 2410-2415, 1993.
8. van der Riet, P. Nawroz, H. Hruban, R.H. Corio, R. Tokino, K. Koch, W. and Sidransky, D. Frequent loss of chromosome 9p. 1-22 early in head and neck cancer progression. Cancer Res. 54: 1156-1158, 1994.
9. Cairns, P. Shaw, M.E. and Knowles, M.A. Initiation of bladder cancer may involve deletion of a tumor suppressor gene on chromosome 9. Oncogene, 8: 1083-1085, 1993.
10. Serrano, M. Hannon, G.J. and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (London), 366: 704-707, 1993.
11. Kamb, A. Gruis, N.A. Weaver-Feldhaus, J. Liu, Q. Harshman, K. Tavtigian, S.V. Stockert, E. Day, R.S. III, Johnson, B.E. and Skolnick, M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
12. Nobori, T. Miura, K. Wu, D.J. Lois, A. Takabayashi, K. and Carson, D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in mutiple human cancers. Nature (Lond.), 238: 753-756, 1994.
13. Mori, T. Miura, K. Aoki, T. Nishihira, T. Mori, S. and Nakamura, Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54: 3396-3397, 1994.
14. Jiang, W. Kahn, S.M. Zhou, P. Zhang, Y.J. Cacace, A.M. Infante, A.S. Doi, S. Santella, R.M. and Weinstein, I.B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8: 3447-3457, 1993.
15. Hainen, M. Tammilehto, L. Mattson, K. and Knuutila, S. Non-random chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet. Cytogenet. 33: 251-274.1988.
16. Hagemeijer, A. Versnel, M.A. Van Drunen, E. Moret, M. Bouts, M.J. van der Kwast, T.H. and Hoogsteden, H.C. Cytogenetic analysis of malignant mesothelioma. Cancer Genet. Cytogenet. 47: 1-28, 1990.
17. Taguchi, T. Jhanwar, S.C. Siegfried, J.M. Keller, S.M. and Testa, J.R. Recurrent deletions of specific chromosomal sites in lp, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res. 53: 4349-4355, 1993.
18. Antman, K.H. Li, F.P. Osteen, R. and Sugarbaker, D.J. Mesothelioma. In: V.T. DeVita, S. Hellman, and S. Rosenberg (eds.), Update, Cancer Principles and Practice, Vol. 3, pp. 1-16. Philadelphia: J.P. Lippincott Co. 1989.
19. Rodriguez, E. Rao, P.H. Ladanyi, M. Altorki, N. Albino, A.P. Kelsen, D.P. Jhanwar, S.C. and Chaganti, R.S.K. 11p. 3-15 is a site of specific chromosome rearrangement in gastric and esophageal adenocarcinomas. Cancer Res. 50: 6410-6416, 1990.
20. Reale, F.R. Griffin, T.W. Compton, J.M. Graham, S. Townes, P.L. and Bogden, A. Characterization of a human malignant mesothelioma cell line (H-MESO-1): A biphasic solid and ascitic tumor model. Cancer Res. 47: 3199-3205, 1987.
21. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
22. Bianchi, A.B. Hara, T. Ramesh, V. Gao, J. Klein-Szanto, A.J.P. Morin, F. Mcnon A.G. Trofattcr, J.A. Gusella, J.F. Seizinger, B.R. and Kley, N. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat. Genet. 6: 185-192, 1994.
23. Stadler, W.M. Sherman, J. Bohlander, S.K. Roulston, D. Dreyling, M. Rukstalis, D. and Olopade, O.I. Homozygous deletions within chromosome bands 9p. 1-22 in bladder cancer. Cancer Res. 54: 2060-2063, 1994.
24. Spruck, C.H. III, Gonzalez-Zullueta, M. Shibata, A. Simoneau, A.R. Lin, M.F. Gonzales, F. Tsal, Y.C. and Jones, P.A. p. 6 gene in uncultured tumours. Nature (Lond.), 370: 183-184, 1994.
25. Gross, P. and Braun, D.C. Asbestos, talc, inorganic fibers, man-made vitreous fibers, and organic fibers. In: Toxic and Biomedical Effects of Fibers, pp. 94-96. Park Ridge, NJ: Noyes, 1984.
26. Fearon, E.R. and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 758-767, 1990.
27. Cote, R.J. Jhanwar, S.C. Novick, S. and Pellicer, A. Genetic alterations of the p. 3 gene are a feature of malignant mesothelioma. Cancer Res. 51: 5410-5416, 1991.
28. Metcalf, R.A. Welsh, J.A. Bennett, W.P. Seddon, M.B. Lehman, T.A. Pelin, K. Linnainmaa, K. Tammilep, L. Mattson, K. Gerwin, B.I. and Harris, C.C. p. 3 and Kirsten-ras mutation in human mesothelioma cell lines. Cancer Res. 52: 2610-2615, 1992.
29. Lu, Y.Y. Jhanwar, S.C. Cheng, J.Q. and Testa, J.R. Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma. Genes Chromosomes Cancer, 9: 76-80, 1994.
30. Marx, J. A challenge to p. 6 gene as a major tumor suppressor. Science (Washington DC), 264: 1846, 1994.
31. Cairns, P. Mao, L. Merlo, A. Lee, D.J. Schwab, D. Eby, Y. Tokino, K. van der Riet, P. Blaugrund, J.E. and Sidransky, D. Rates of p. 6 (MTS1) mutations in primary tumors with 9p loss. Science (Washington DC), 265: 415-416, 1994.
32. de Fromentel, C.C. and Soussi, T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer, 4: 1-15, 1992.
33. Holland, E.A. Beaton, S.C. Edwards, B.G. Kefford, R.F. and Mann, G.J. Loss of heterozygosity and homozygous deletions on 9p. 1-22 in melanoma. Oncogene, 9: 1361-1365, 1994.
34. Coleman, A. Fountain, J.W. Nobori, T. Olopade, O.I. Robertson, G. Housman, D.E. and Lugo, T.G. Distinct deletion of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res. 54: 344-348, 1994.